Josh’s two-plus decades of specialty pharmaceutical and life sciences experience have been focused primarily on leading companies through periods of dynamic growth. He has served in senior commercial executive roles comprising corporate development, marketing, and sales, and has helped mold energized company cultures and strategies that support and sustain organizational success.

In November 2019, Josh joined Pharmacosmos Therapeutics as Chief Commercial Officer. He was appointed President in May of 2022. Previously, Josh was Senior Vice President of Marketing and Corporate Development at Chiesi USA, Inc.

Josh holds Master of Business Administration and Master of Health Administration degrees from the Ohio State University and is a veteran of the United States Army.

You are about to leave the Pharmacosmos Therapeutics US website.

Please identify if you are a:


Please identify if you are a: